You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞信窩輪》貿戰憂慮手機股捱沽,留意舜光購28792、瑞聲購12835
阿思達克 11-11 10:57

市場對貿戰憂慮重燃,手機設備股舜宇光學(2382)雖然公布,上月手機鏡頭出貨量按年升約42%,不過股價周一曾急跌逾7%,及後跌幅收窄,但仍受制於130元關口。向上觀望突破近日高位136.5元的機會,支持參考120元水平。看好可留意舜光購28792,行使價148.48元,20年3月到期。或舜光牛65544,收回價115.28元,行使價111.28元,20年12月到期。相反看淡可留意舜光沽28496,行使價108.88元,20年3月到期。或舜光熊55550,收回價138.68元,行使價142.68元,20年6月到期。

瑞聲科技(2018)首三季少賺約46%,兼且被券商唱淡,周一低位曾跌近6%,其後跌幅收窄,但仍受制於50元關口。觀望反彈,看好可留意瑞聲購12835,行使價61.88元,20年5月到期。或瑞聲牛62954,收回價45.38元,行使價42.38元,20年7月到期。相反看淡可留意瑞聲沽11124,行使價49.83元,20年5月到期。或瑞聲熊62957,收回價58.88元,行使價61.88元,20年5月到期。

外電引述消息指,內地考慮明年起削減購買電動車的補貼。吉利汽車(0175)周一曾跌逾3%,險守15元。向上觀望重上近日高位15.78元的機會,支持參考15元水平。看好可留意吉利購12487,行使價16.88元,20年4月到期。或50兌1吉利牛64358,收回價14.38元,行使價13.88元,20年10月到期。相反看淡可留意吉利沽12676,行使價14.38元,20年5月到期。或50兌1吉利熊59534,收回價16.08元,行使價16.58元,20年1月到期。

強勢醫藥股石藥集團(1093)周一曾逆市上升,其後於20元以上整固。看好可考慮石藥購12746,行使價22.88元,20年7月到期。相反看淡可留意石藥沽12763,行使價17.78元,20年5月到期。中國生物製藥(1177)成為國指新貴,周一亦曾向上,其後大市跌幅擴大,股價呈反覆偏軟。看好可考慮中藥購23888,行使價12.68元,20年2月到期。相反看淡可考慮中藥沽26729,行使價10.88元,20年3月到期。

(本結構性產品並無抵押品)

《瑞信香港認股證及牛熊證銷售主管何啟聰》

免責聲明:筆者為瑞士信貸(香港)有限公司的代表 ,並身為證監會持牌人,並無持有相關上市公司的任何財務權益。本文內容僅供參考,並不構成要約、建議或促使任何人士提呈買賣或認購任何證券。結構性產品價格可急升或急跌,投資者或會蒙受全盤損失。本產品並無抵押品。如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。牛熊證備強制贖回機制而可能被提早終止,屆時(i)N類牛熊證投資者將不獲發任何金額;而(ii)R類牛熊證之剩餘價值可能為零。有關恆生指數或恆生中國企業指數的免責聲明,請參閱上市文件。過往表現並不反映將來表現。投資前,投資者應瞭解風險,並諮詢專業顧問及查閱有關上市文件。瑞信之聯屬公司為結構性產品之流通量提供者,亦可能是唯一報價者。本文任何內容概不構成投資、法律、會計或稅務意見、並無聲明任何投資或策略適合或符合閣下的個別情況。結構性產品交投量並不是結構性產品表現的指標,投資者不應僅依賴交投量歷史高位數據以釐定結構性產品日後的表現。~重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account